Search

Keith C. Furman

Examiner (ID: 17020)

Most Active Art Unit
1814
Art Unit(s)
1646, 1806, 1801, 1814
Total Applications
280
Issued Applications
140
Pending Applications
17
Abandoned Applications
123
Applications
StatisticsSubscription-Only

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 2894446 [patent_doc_number] => 05270449 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-12-14 [patent_title] => 'Methods for the isolation of heparin-binding brain mitogens' [patent_app_type] => 1 [patent_app_number] => 7/944604 [patent_app_country] => US [patent_app_date] => 1992-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6204 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/270/05270449.pdf [firstpage_image] =>[orig_patent_app_number] => 944604 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/944604 		Methods for the isolation of heparin-binding brain mitogens Sep 13, 1992 Issued
07/938307 BIOACTIVE PHARMACEUTICAL Aug 27, 1992 Abandoned
Array ( [id] => 3422535 [patent_doc_number] => 05415859 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-16 [patent_title] => 'Production and use of antheimintic agents and protective antigens' [patent_app_type] => 1 [patent_app_number] => 7/928187 [patent_app_country] => US [patent_app_date] => 1992-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2646 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/415/05415859.pdf [firstpage_image] =>[orig_patent_app_number] => 928187 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/928187 		Production and use of antheimintic agents and protective antigens Aug 13, 1992 Issued
07/927864 VLA PROTEINS Aug 9, 1992 Abandoned
07/924393 PURIFICATION OF VON WILLEBRAND FACTOR BY AFFINITY CHROMATOGRAPHY Aug 2, 1992 Abandoned
07/923094 GENETICALLY ENGINEERED EUKARYOTIC ORGANISM CAPABLE OF DETECTING THE EXPRESSION OF HETEROLOGOUS ION CHANNELS AND METHOD TO USE THE SAME Jul 30, 1992 Abandoned
07/921180 BIOACTIVE PHARMACEUTICALS Jul 29, 1992 Abandoned
07/908507 SNRNP-A ANTIGEN AND FRAGMENTS THEREOF Jun 29, 1992 Abandoned
07/901545 NUCLEIC ACID PREPARATION METHODS Jun 18, 1992 Abandoned
07/898248 MODIFIED FACTOR VII/VIIA Jun 11, 1992 Abandoned
07/896003 FUSION PROTEINS Jun 10, 1992 Abandoned
07/852212 NOVEL VACCINE May 28, 1992 Abandoned
Array ( [id] => 3480625 [patent_doc_number] => 05399668 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-21 [patent_title] => 'CDNA encoding a polypeptide including a hevein sequence' [patent_app_type] => 1 [patent_app_number] => 7/888364 [patent_app_country] => US [patent_app_date] => 1992-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 6090 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/399/05399668.pdf [firstpage_image] =>[orig_patent_app_number] => 888364 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/888364 		CDNA encoding a polypeptide including a hevein sequence May 25, 1992 Issued
Array ( [id] => 3526952 [patent_doc_number] => 05504194 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-02 [patent_title] => 'Lymphocyte adhesion receptor for high endothelium, CD44' [patent_app_type] => 1 [patent_app_number] => 7/884624 [patent_app_country] => US [patent_app_date] => 1992-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 7625 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/504/05504194.pdf [firstpage_image] =>[orig_patent_app_number] => 884624 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/884624 		Lymphocyte adhesion receptor for high endothelium, CD44 May 14, 1992 Issued
07/883457 ENDOTOXIN BINDING AND NEUTRALIZING PROTEIN AND USES THEREOF May 14, 1992 Abandoned
07/856910 MAMMALIAN PANCREATIC CHOLESTEROL ESTERASE May 11, 1992 Abandoned
Array ( [id] => 2884733 [patent_doc_number] => 05268363 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-12-07 [patent_title] => 'Method of treatment to inhibit the undesirable activation of the complement cascade with factor J, an inhibitor of complement C1' [patent_app_type] => 1 [patent_app_number] => 7/874620 [patent_app_country] => US [patent_app_date] => 1992-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 3442 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/268/05268363.pdf [firstpage_image] =>[orig_patent_app_number] => 874620 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/874620 		Method of treatment to inhibit the undesirable activation of the complement cascade with factor J, an inhibitor of complement C1 Apr 26, 1992 Issued
Array ( [id] => 2964366 [patent_doc_number] => 05264549 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-23 [patent_title] => 'Characterization and method of isolation of factor J, an inhibitor of complement C1' [patent_app_type] => 1 [patent_app_number] => 7/874714 [patent_app_country] => US [patent_app_date] => 1992-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 3469 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/264/05264549.pdf [firstpage_image] =>[orig_patent_app_number] => 874714 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/874714 		Characterization and method of isolation of factor J, an inhibitor of complement C1 Apr 26, 1992 Issued
07/874466 CAFFEOYL-COA 3-0-METHYLTRANSFERASE GENES Apr 26, 1992 Abandoned
07/873304 PRODUCTION OF RECOMBINANT HUMAN LACTOFERRIN Apr 23, 1992 Abandoned
Menu